These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 9127013)
1. HIV-1 env DNA vaccine administered to rhesus monkeys elicits MHC class II-restricted CD4+ T helper cells that secrete IFN-gamma and TNF-alpha. Lekutis C; Shiver JW; Liu MA; Letvin NL J Immunol; 1997 May; 158(9):4471-7. PubMed ID: 9127013 [TBL] [Abstract][Full Text] [Related]
2. HIV-1 envelope-specific CD4+ T helper cells from simian/human immunodeficiency virus-infected rhesus monkeys recognize epitopes restricted by MHC class II DRB1*0406 and DRB*W201 molecules. Lekutis C; Letvin NL J Immunol; 1997 Aug; 159(4):2049-57. PubMed ID: 9257873 [TBL] [Abstract][Full Text] [Related]
3. Production of transmembrane and secreted forms of tumor necrosis factor (TNF)-alpha by HIV-1-specific CD4+ cytolytic T lymphocyte clones. Evidence for a TNF-alpha-independent cytolytic mechanism. Liu AY; Miskovsky EP; Stanhope PE; Siliciano RF J Immunol; 1992 Jun; 148(12):3789-98. PubMed ID: 1351088 [TBL] [Abstract][Full Text] [Related]
4. An HIV-1 envelope protein vaccine elicits a functionally complex human CD4+ T cell response that includes cytolytic T lymphocytes. Stanhope PE; Liu AY; Pavlat W; Pitha PM; Clements ML; Siliciano RF J Immunol; 1993 May; 150(10):4672-86. PubMed ID: 8097759 [TBL] [Abstract][Full Text] [Related]
5. Helper-cytotoxic T lymphocyte (CTL) determinant linkage required for priming of anti-HIV CD8+ CTL in vivo with peptide vaccine constructs. Shirai M; Pendleton CD; Ahlers J; Takeshita T; Newman M; Berzofsky JA J Immunol; 1994 Jan; 152(2):549-56. PubMed ID: 8283036 [TBL] [Abstract][Full Text] [Related]
6. Improving recombinant MVA immune responses: potentiation of the immune responses to HIV-1 with MVA and DNA vectors expressing Env and the cytokines IL-12 and IFN-gamma. Abaitua F; Rodríguez JR; Garzón A; Rodríguez D; Esteban M Virus Res; 2006 Mar; 116(1-2):11-20. PubMed ID: 16214252 [TBL] [Abstract][Full Text] [Related]
7. Efficient CD8+ T cell response to the HIV-env V3 loop epitope from multiple virus isolates by a DNA prime/vaccinia virus boost (rWR and rMVA strains) immunization regime and enhancement by the cytokine IFN-gamma. Gómez CE; Abaitua F; Rodríguez D; Esteban M Virus Res; 2004 Sep; 105(1):11-22. PubMed ID: 15325077 [TBL] [Abstract][Full Text] [Related]
8. Progress toward an artificial vaccine for HIV: identification of helper and cytotoxic T-cell epitopes and methods of immunization. Berzofsky JA Biotechnol Ther; 1991; 2(1-2):123-35. PubMed ID: 1726961 [TBL] [Abstract][Full Text] [Related]
9. Synthetic peptide in mineral oil adjuvant elicits simian immunodeficiency virus-specific CD8+ cytotoxic T lymphocytes in rhesus monkeys. Yasutomi Y; Palker TJ; Gardner MB; Haynes BF; Letvin NL J Immunol; 1993 Nov; 151(9):5096-105. PubMed ID: 7691965 [TBL] [Abstract][Full Text] [Related]
10. Class I- and class II-reactive TCRs coexpressed on CD4+ T cells both trigger CD4/CD8-shared and CD4-unique functions. Asnagli H; Schmitt-Verhulst AM; Guimezanes A J Immunol; 1997 May; 158(10):4533-42. PubMed ID: 9144464 [TBL] [Abstract][Full Text] [Related]
11. Engineering immunogenic consensus T helper epitopes for a cross-clade HIV vaccine. De Groot AS; Bishop EA; Khan B; Lally M; Marcon L; Franco J; Mayer KH; Carpenter CC; Martin W Methods; 2004 Dec; 34(4):476-87. PubMed ID: 15542374 [TBL] [Abstract][Full Text] [Related]
12. HIV p24-specific helper T cell clones from immunized primates recognize highly conserved regions of HIV-1. Mills KH; Kitchin PA; Mahon BP; Barnard AL; Adams SE; Kingsman SM; Kingsman AJ J Immunol; 1990 Mar; 144(5):1677-83. PubMed ID: 1689753 [TBL] [Abstract][Full Text] [Related]
13. Antigenicity of HIV-derived T helper determinants in the context of carrier recombinant proteins: effect on T helper cell repertoire selection. Manca F; De Berardinis P; Fenoglio D; Ombra MN; Li Pira G; Saverino D; Autiero M; Lozzi L; Bracci L; Guardiola J Eur J Immunol; 1996 Oct; 26(10):2461-9. PubMed ID: 8898961 [TBL] [Abstract][Full Text] [Related]
14. Development of HIV/AIDS vaccine using chimeric gag-env virus-like particles. Kang CY; Luo L; Wainberg MA; Li Y Biol Chem; 1999 Mar; 380(3):353-64. PubMed ID: 10223338 [TBL] [Abstract][Full Text] [Related]
15. Priming with T helper cell epitope peptides enhances the antibody response to the envelope glycoprotein of HIV-1 in primates. Hosmalin A; Nara PL; Zweig M; Lerche NW; Cease KB; Gard EA; Markham PD; Putney SD; Daniel MD; Desrosiers RC J Immunol; 1991 Mar; 146(5):1667-73. PubMed ID: 1704401 [TBL] [Abstract][Full Text] [Related]
16. DNA vaccination of macaques by a full genome HIV-1 plasmid which produces noninfectious virus particles. Akahata W; Ido E; Shimada T; Katsuyama K; Yamamoto H; Uesaka H; Ui M; Kuwata T; Takahashi H; Hayami M Virology; 2000 Sep; 275(1):116-24. PubMed ID: 11017793 [TBL] [Abstract][Full Text] [Related]
17. Hemagglutinating virus of Japan protein is efficient for induction of CD4+ T-cell response by a hepatitis B core particle-based HIV vaccine. Takeda S; Shiosaki K; Kaneda Y; Nakasatomi T; Yoshizaki H; Someya K; Konno Y; Eda Y; Kino Y; Yamamoto N; Honda M Clin Immunol; 2004 Jul; 112(1):92-105. PubMed ID: 15207786 [TBL] [Abstract][Full Text] [Related]
18. Deoxyribonucleic acid (DNA) encoding a pan-major histocompatibility complex class II peptide analogue augmented antigen-specific cellular immunity and suppressive effects on tumor growth elicited by DNA vaccine immunotherapy. Teramoto K; Kontani K; Ozaki Y; Sawai S; Tezuka N; Nagata T; Fujino S; Itoh Y; Taguchi O; Koide Y; Asai T; Ohkubo I; Ogasawara K Cancer Res; 2003 Nov; 63(22):7920-5. PubMed ID: 14633722 [TBL] [Abstract][Full Text] [Related]
19. Polygene DNA vaccine induces a high level of protective effect against HIV-vaccinia virus challenge in mice. Shinoda K; Xin KQ; Jounai N; Kojima Y; Tamura Y; Okada E; Kawamoto S; Okuda K; Klinman D; Okuda K Vaccine; 2004 Sep; 22(27-28):3676-90. PubMed ID: 15315847 [TBL] [Abstract][Full Text] [Related]
20. Identification of a major human immunodeficiency virus-1 reverse transcriptase epitope recognized by mouse CD4+ T lymphocytes. Haas G; David R; Frank R; Gausepohl H; Devaux C; Claverie JM; Pierres M Eur J Immunol; 1991 Jun; 21(6):1371-7. PubMed ID: 1710563 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]